Diabetes UK is looking for 16 enthusiastic clinicians who want to be local ‘Clinical Champions’ and deliver the leadership to improve services for people with diabetes. The roles are open to any ...
Novo Nordisk has launched NovoRapid® PumpCart®, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps. This new treatment solution, ...
Cultural attitudes amongst the South Asian community towards diabetes are changing for the better, according to a report presented to the House of Lords this week. The work by South Asian Health ...
Almost 150 diabetes hospital teams took part in Hypo Awareness Week 2014. The aim of the week, which ran from September 29 to October 5, was to raise awareness of hypoglycaemia in the inpatient ...
An awareness campaign to encourage people to talk about hypoglycaemia has been launched ahead of Hypo Awareness Week. TALK Hypos aims to improve recognition and management of one of the most ...
The first all-diabetes professional cycling team will be competing on British roads for the first time later this month in the country’s leading race. Team Novo Nordisk will be taking part in The ...
Diabetes hospital teams are being invited to take part in Hypo Awareness Week 2014. The aim of the week, which runs from September 29 to October 5, is to raise awareness of hypoglycaemia in the ...
A drug combining Novo Nordisk’s long-acting insulin degludec with its Type 2 diabetes treatment Victoza has been recommended for approval in Europe. The Committee for Medicinal Products ...
Novo Nordisk’s degludec/liraglutide (Xultophy, formerly known as IDegLira) is set to become the clinical gold standard among fixed-dose combination (FDC) therapy insulin used to treat ...
Pharmaceutical giant Novo Nordisk has announced the launch of ‘Cities Changing Diabetes’, an ambitious new partnership programme to fight the urban diabetes challenge. The ...